283 related articles for article (PubMed ID: 24390736)
1. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1.
Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; Wang J; Qi R; Matzuk AJ; Song X; Madoux F; Hodder P; Chase P; Griffin PR; Zhou S; Liao L; Xu J; O'Malley BW
Cancer Res; 2014 Mar; 74(5):1506-1517. PubMed ID: 24390736
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1.
Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; O'Malley BW
Mol Endocrinol; 2011 Dec; 25(12):2041-53. PubMed ID: 22053001
[TBL] [Abstract][Full Text] [Related]
3. Steroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug.
Song X; Zhang C; Zhao M; Chen H; Liu X; Chen J; Lonard DM; Qin L; Xu J; Wang X; Li F; O'Malley BW; Wang J
PLoS One; 2015; 10(10):e0140011. PubMed ID: 26431029
[TBL] [Abstract][Full Text] [Related]
4. Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells.
Rohira AD; Yan F; Wang L; Wang J; Zhou S; Lu A; Yu Y; Xu J; Lonard DM; O'Malley BW
Cancer Res; 2017 Aug; 77(16):4293-4304. PubMed ID: 28611048
[TBL] [Abstract][Full Text] [Related]
5. Bufalin is a steroid receptor coactivator inhibitor-letter.
Calderón-Montaño JM; Burgos-Morón E; Orta ML; García-Domínguez I; Maldonado-Navas D; López-Lázaro M
Cancer Res; 2015 Mar; 75(6):1156. PubMed ID: 25736686
[No Abstract] [Full Text] [Related]
6. Bufalin is a steroid receptor coactivator inhibitor-response.
Lonard DM; Xu J; O'Malley BW
Cancer Res; 2015 Mar; 75(6):1157. PubMed ID: 25736684
[No Abstract] [Full Text] [Related]
7. Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death.
Wang L; Yu Y; Chow DC; Yan F; Hsu CC; Stossi F; Mancini MA; Palzkill T; Liao L; Zhou S; Xu J; Lonard DM; O'Malley BW
Cancer Cell; 2015 Aug; 28(2):240-52. PubMed ID: 26267537
[TBL] [Abstract][Full Text] [Related]
8. The cooperative function of nuclear receptor coactivator 1 (NCOA1) and NCOA3 in placental development and embryo survival.
Chen X; Liu Z; Xu J
Mol Endocrinol; 2010 Oct; 24(10):1917-34. PubMed ID: 20685850
[TBL] [Abstract][Full Text] [Related]
9. Identification of verrucarin a as a potent and selective steroid receptor coactivator-3 small molecule inhibitor.
Yan F; Yu Y; Chow DC; Palzkill T; Madoux F; Hodder P; Chase P; Griffin PR; O'Malley BW; Lonard DM
PLoS One; 2014; 9(4):e95243. PubMed ID: 24743578
[TBL] [Abstract][Full Text] [Related]
10. The role of SRC-1 in murine prostate cancinogenesis is nonessential due to a possible compensation of SRC-3/AIB1 overexpression.
Tien JC; Zhou S; Xu J
Int J Biol Sci; 2009; 5(3):256-64. PubMed ID: 19305643
[TBL] [Abstract][Full Text] [Related]
11. SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma.
Song X; Chen H; Zhang C; Yu Y; Chen Z; Liang H; Van Buren G; McElhany AL; Fisher WE; Lonard DM; O'Malley BW; Wang J
Cancer Lett; 2019 Feb; 442():310-319. PubMed ID: 30423406
[TBL] [Abstract][Full Text] [Related]
12. An acetylation-enhanced interaction between transcription factor Sox2 and the steroid receptor coactivators facilitates Sox2 transcriptional activity and function.
Huang Y; Duan X; Wang Z; Sun Y; Guan Q; Kang L; Zhang Q; Fang L; Li J; Wong J
J Biol Chem; 2021 Dec; 297(6):101389. PubMed ID: 34762910
[TBL] [Abstract][Full Text] [Related]
13. Review of the in vivo functions of the p160 steroid receptor coactivator family.
Xu J; Li Q
Mol Endocrinol; 2003 Sep; 17(9):1681-92. PubMed ID: 12805412
[TBL] [Abstract][Full Text] [Related]
14. Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3.
Song X; Chen J; Zhao M; Zhang C; Yu Y; Lonard DM; Chow DC; Palzkill T; Xu J; O'Malley BW; Wang J
Proc Natl Acad Sci U S A; 2016 May; 113(18):4970-5. PubMed ID: 27084884
[TBL] [Abstract][Full Text] [Related]
15. miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.
Eedunuri VK; Rajapakshe K; Fiskus W; Geng C; Chew SA; Foley C; Shah SS; Shou J; Mohamed JS; Coarfa C; O'Malley BW; Mitsiades N
Mol Endocrinol; 2015 Aug; 29(8):1170-83. PubMed ID: 26066330
[TBL] [Abstract][Full Text] [Related]
16. SRC-3 has a role in cancer other than as a nuclear receptor coactivator.
Ma G; Ren Y; Wang K; He J
Int J Biol Sci; 2011; 7(5):664-72. PubMed ID: 21647249
[TBL] [Abstract][Full Text] [Related]
17. Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.
Karmakar S; Foster EA; Smith CL
Endocrinology; 2009 Apr; 150(4):1588-96. PubMed ID: 19095746
[TBL] [Abstract][Full Text] [Related]
18. Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.
Rohira AD; Lonard DM
Biochem Pharmacol; 2017 Sep; 140():1-7. PubMed ID: 28390937
[TBL] [Abstract][Full Text] [Related]
19. The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism.
Jeong JW; Kwak I; Lee KY; White LD; Wang XP; Brunicardi FC; O'Malley BW; DeMayo FJ
Mol Endocrinol; 2006 May; 20(5):1138-52. PubMed ID: 16423883
[TBL] [Abstract][Full Text] [Related]
20. Role of P53-Senescence Induction in Suppression of LNCaP Prostate Cancer Growth by Cardiotonic Compound Bufalin.
Zhang Y; Dong Y; Melkus MW; Yin S; Tang SN; Jiang P; Pramanik K; Wu W; Kim S; Ye M; Hu H; Lu J; Jiang C
Mol Cancer Ther; 2018 Nov; 17(11):2341-2352. PubMed ID: 30166403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
